DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TNFRSF13B; LILRA1; EGFR; F2; IFNG; IL2RA; CD3D; CD3G; CCL2; EDN3; EDNRB; KLRC1; BDKRB2; GLP1R; CXCR3; CCR5; ADGRE1; ADGRF1; ADGRG6; ADGRF2; LILRB2; CLEC1A; GLMN; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; ANXA1; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	75	268	27.9850746268657	0	0	0	0	0	0	0
down	TLL1; SOX15; INHA; FGF1; ROS1; ANXA13; FOXL2; KRTDAP; BNC1; NHLH2; SIM2; OSR1; TWIST2; RAI14; NDRG4; DLX1; DLX2; NKX2-8; HES7; NR2F2; FOXA2; SPINK6; CAV1; HNF4A; SPDEF; FOXC2; NKX3-2; HNF4G; FOXD1; FSTL1; FRK; HES2; NKX1-2; ONECUT2;	GO:0030154~cell differentiation	34	572	5.94405594405594	0	0	0	0	0	0	0
down	KRT34; KRT75; KRT14; KRT6B; KRT18; KRT8; IVL; KRT19; KRT16; KRT10; KRT4; PI3; FLG; SPRR1B; SPRR2E; SPRR2D; SPRR1A; SPRR2A; KRT20; KRT6C; KRT17; KRT33B; KRT31; SPINK6; SPRR3; KLK13; KLK5;	GO:0070268~cornification	27	113	23.8938053097345	0	0	0	0	0	0	0
down	GDNF; DLX1; ISL1; GRIK2; SIX1; SNCB; VSTM2L; SIX4; NTF4;	GO:0043524~negative regulation of neuron apoptotic process	9	138	6.52173913043478	0.00010246216583598	0.00330185727032962	0.217322253738117	0.224084756683291	0.182690041685555	0.217322253738117	0.027298865373239
down	NKX3-2; SHH; GATA6;	GO:0048645~animal organ formation	3	5	60	0.00010266405778802	0.00330185727032962	0.217647802510617	0.224526294382414	0.182947350978264	0.217647802510617	0.027298865373239
down	BMP2; SOX9; DLX1; GATA6; TMEM100;	GO:0071773~cellular response to BMP stimulus	5	33	15.1515151515152	0.00010533174233318	0.00333855826786474	0.223197962004011	0.230360520482667	0.186121188702731	0.223197962004011	0.0276022993223009
down	KRT6B; KRT16; KRT4; SOX9; FGD1; KRT31; MARK1; PAK5; PCLO;	GO:0007010~cytoskeleton organization	9	139	6.47482014388489	0.00010790734929466	0.00337133389867767	0.228547765806105	0.235993372907437	0.189161583313551	0.228547765806105	0.027873279398007
down	TBX3; HOXC11; GLI2; SHH; TWIST1; OSR1;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.00011316109370573	0.00348568044978098	0.239562035375048	0.247483311934449	0.19542920882981	0.239562035375048	0.0288186658423314
down	ASTN1; CCK; NR2F2; CDK5R2; TWIST1; ADGRL3; MARK1; DCDC2;	GO:0001764~neuron migration	8	109	7.3394495412844	0.00011508812796889	0.0034958018870553	0.24352647878219	0.251697735867981	0.197721403850568	0.24352647878219	0.0289023471558813
down	SOX9; SHH; SMO; FOXA2; TBX3;	GO:0001708~cell fate specification	5	34	14.7058823529412	0.00011958867633621	0.00353433020469322	0.252930050451091	0.261540435147298	0.202583217713545	0.252810461774754	0.0292208888947099
down	SOX9; SHH; SIX1; SMO; SIX4;	GO:0034504~protein localization to nucleus	5	34	14.7058823529412	0.00011958867633621	0.00353433020469322	0.252930050451091	0.261540435147298	0.202583217713545	0.252810461774754	0.0292208888947099
down	KLK8; KCNK2; CCK; HRH1; PLK2; PAK5; NTF4;	GO:0007613~memory	7	83	8.43373493975904	0.00013758203044855	0.00401189200787994	0.290710830337802	0.300891900590995	0.220543994809038	0.290710830337802	0.0331692410811429
down	BMP2; SOX9; ISL1; TWIST1;	GO:0003203~endocardial cushion morphogenesis	4	18	22.2222222222222	0.00014572218325703	0.00419334756293601	0.307765251038859	0.318694414783137	0.227909494614003	0.307765251038859	0.0346694666703028
down	WNT9A; GDNF; DLX1; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00015249573834919	0.00422363665347637	0.321766007916791	0.333508179769678	0.234080958366006	0.321766007916791	0.0349198887016756
down	SOX9; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.00015256849365552	0.00422363665347637	0.321766953119502	0.333667295624633	0.2341757634599	0.321766953119502	0.0349198887016756
down	EPCAM; LHX1; SIX1; OSR1; FOXC2;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00017133832802995	0.00457431657825002	0.36118119548715	0.374716923401517	0.250839312235858	0.36118119548715	0.0378192157384672
down	GLI2; MSX2; SHH; PTHLH;	GO:0002076~osteoblast development	4	19	21.0526315789474	0.00017466604939753	0.00457431657825002	0.368021366080599	0.381994650032402	0.253615103725216	0.367672033981804	0.0378192157384672
down	POSTN; SEMA6D; HAS2; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.00017466604939753	0.00457431657825002	0.368021366080599	0.381994650032402	0.253615103725216	0.367672033981804	0.0378192157384672
down	SERPINE2; NTF4; ISL1; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.00017466604939753	0.00457431657825002	0.368021366080599	0.381994650032402	0.253615103725216	0.367672033981804	0.0378192157384672
down	GJC1; CAV1; SHH; HAS2; SMO; TMEM100;	GO:0001570~vasculogenesis	6	60	10	0.00017569391521399	0.00457431657825002	0.36965999761024	0.384242592573002	0.254493972675695	0.36965999761024	0.0378192157384672
down	FGF5; EPCAM; MSX2; HNF4A;	GO:0023019~signal transduction involved in regulation of gene expression	4	20	20	0.00020753921121297	0.00527777040607868	0.436454961180877	0.453888254922766	0.277687464602954	0.436247421969664	0.0436351822597175
down	EPCAM; TWIST1; DUOXA2; DUOX2;	GO:2000147~positive regulation of cell motility	4	20	20	0.00020753921121297	0.00527777040607868	0.436454961180877	0.453888254922766	0.277687464602954	0.436247421969664	0.0436351822597175
down	LHX1; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00021593573386358	0.00542817758574313	0.453680976847385	0.472251449959653	0.283739554296746	0.453680976847385	0.0448787082551397
down	DSCAM; SLITRK6; ADGRL3; PCDHB10; PCDHB4; PCLO;	GO:0007416~synapse assembly	6	63	9.52380952380952	0.00022462143117385	0.00558235306792296	0.471705005465095	0.49124706997722	0.289986267645447	0.471705005465095	0.046153389559417
down	TBX3; FOXF2; SHH; TWIST1; ALX1; OSR1;	GO:0060021~roof of mouth development	6	66	9.09090909090909	0.00028368510245546	0.00695671392664781	0.595455030054024	0.620419319070105	0.326432504263771	0.595455030054024	0.0575162344630167
down	TBX3; GLI2; SOX9; CAV1;	GO:0030879~mammary gland development	4	22	18.1818181818182	0.00028628452373036	0.00695671392664781	0.6006249307863	0.626104253398303	0.327795779671265	0.6006249307863	0.0575162344630167
down	BMP2; ISL1; TWIST1; ALX1; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	5	42	11.9047619047619	0.00029354161369143	0.00699275640892455	0.615556763910948	0.641975509143178	0.331745293019001	0.615556763910948	0.0578142239855293
down	SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00029416259241932	0.00699275640892455	0.6165647937109	0.643333589621058	0.332109566841415	0.6165647937109	0.0578142239855293
down	CXCL11; RBFOX2; CXCL10; INHA; NOS2; SOX9; CXCL9; SHH; FRK;	GO:0042127~regulation of cell population proliferation	9	163	5.52147239263804	0.00033243315649611	0.00774231161139477	0.69644746285936	0.727031313257003	0.350384546946905	0.69644746285936	0.0640113442383992
down	PROM1; DSCAM; LHX1; FJX1;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.0003327742530732	0.00774231161139477	0.6968292859353	0.727777291471108	0.350453035291288	0.6968292859353	0.0640113442383992
down	WNT9A; TNC; SOX9; WNT7B; OSR1; FZD10;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.00035429362293992	0.00814479372412352	0.741536552813268	0.774840153369621	0.359458794486034	0.741536552813268	0.0673389577937308
down	AKR1B15; AKR1B10; CYP1A1; ALDH1A3; CYP27C1;	GO:0042572~retinol metabolic process	5	44	11.3636363636364	0.00035752180956372	0.00814479372412352	0.747935625607305	0.781900197515858	0.360739505849795	0.747935625607305	0.0673389577937308
down	WNT9A; HOXC8; WNT7B; FZD8; BTG4; FZD10; LHX5; LHX1;	GO:0030182~neuron differentiation	8	131	6.10687022900763	0.00037442676018184	0.00841969926215432	0.782926355540238	0.818871324517695	0.36761677568106	0.782926355540238	0.0696118026379028
down	CLDN1; KRT14; CYP1A1; COL4A2; KRT16; MMP7; NQO1; KRT33B; LOXL2;	GO:0007568~aging	9	166	5.42168674698795	0.00037728876437637	0.00841969926215432	0.788533517546616	0.825130527691124	0.368611122795715	0.788533517546616	0.0696118026379028
down	TBX3; CXCL14; CXCL10; SOX9;	GO:0045662~negative regulation of myoblast differentiation	4	24	16.6666666666667	0.00038442734008725	0.00849234942192758	0.803068713442279	0.84074259277083	0.371412231031147	0.803068713442279	0.0702124545645672
down	SIX1; SMO; SIX4;	GO:0051451~myoblast migration	3	9	33.3333333333333	0.00038858760709792	0.00849841096723158	0.811370923620464	0.849841096723158	0.373044102814006	0.811370923620464	0.0702625697862925
down	MYL2; COL11A1; ISL1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	4	25	16	0.00044156217223356	0.00956135119480011	0.921540253451455	0.965696470674811	0.39379180839421	0.921540253451455	0.079050672904177
down	PLAT; SERPINE2; F3; HNF4A; TFPI2; DOCK1; SHH; GATA6; SERPINA10;	GO:0007596~blood coagulation	9	171	5.26315789473684	0.00046307127138334	0.00983239680112008	0.965503600834268	1	0.402059014272713	0.965503600834268	0.081291604874019
down	CXCL14; BCAR1; ARHGEF16; SAA2; SAA1; CXCR1;	GO:0060326~cell chemotaxis	6	74	8.10810810810811	0.00050176225463727	0.0105514812585742	1	1	0.417163783305499	0.987363058278333	0.0872368012253041
down	SAA1; CXCL9; CXCR1; CXCL10; CCL26; CXCL11;	GO:0030593~neutrophil chemotaxis	6	76	7.89473684210526	0.00057257816827505	0.0119259852763575	1	1	0.44321486894336	0.987363058278333	0.098600829729388
down	PIGR; SOX9; BCAR1; EFEMP1; FAM83A;	GO:0007173~epidermal growth factor receptor signaling pathway	5	50	10	0.00061346085486047	0.0124225823109245	1	1	0.45641487601619	0.987363058278333	0.102706560074916
down	NR2F2; CAV1; SIX1; SIX4; POPDC3;	GO:0007519~skeletal muscle tissue development	5	50	10	0.00061346085486047	0.0124225823109245	1	1	0.45641487601619	0.987363058278333	0.102706560074916
down	SIX1; NR2F2; HNF4A; SIX4; HNF4G;	GO:0048856~anatomical structure development	5	50	10	0.00061346085486047	0.0124225823109245	1	1	0.45641487601619	0.987363058278333	0.102706560074916
down	CXCL11; CXCL10; CCL26;	GO:0010818~T cell chemotaxis	3	11	27.2727272727273	0.00063110381927655	0.012662605988604	1	1	0.46196799571044	0.987363058278333	0.104691011105625
down	GLI2; KRT17; SHH; SMO;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00064908201408542	0.0127886699531966	1	1	0.467858913462197	0.987363058278333	0.105733273964397
down	MMP2; COL4A2; COL11A1; COL12A1;	GO:0035987~endodermal cell differentiation	4	28	14.2857142857143	0.00064908201408542	0.0127886699531966	1	1	0.467858913462197	0.987363058278333	0.105733273964397
down	COL4A1; EDNRA; SHH; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	4	29	13.7931034482759	0.0007313791003144	0.0142814829677464	1	1	0.492949513611906	0.987363058278333	0.118075449344845
down	HRH1; CAV1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00082078441825028	0.0158854471036582	1	1	0.512444864518216	0.987363058278333	0.131336592218349
down	ONECUT2; BMP2; WNT7B; GATA6; WNT9A;	GO:0045165~cell fate commitment	5	55	9.09090909090909	0.00091523884974542	0.0159273842261521	1	1	0.531730045362141	0.987363058278333	0.131683317036345
down	GLI2; LHX1; SHH; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.00091762707475773	0.0159273842261521	1	1	0.532219119432404	0.987363058278333	0.131683317036345
up	FCN1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-1; IGKC; IGHG2; IGHG3; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3;	GO:0006956~complement activation	20	92	21.7391304347826	0.00094558370677555	0.499425794461955	1	1	0.999999999999999	0.999999999999999	1
down	NQO1; NOS1; NOS2;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.00095308321390807	0.0161580851846277	1	1	0.539299889730358	0.987363058278333	0.13359069033909
down	DLX1; DLX2; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.00095308321390807	0.0161580851846277	1	1	0.539299889730358	0.987363058278333	0.13359069033909
down	EDNRA; LHX1; STRA6;	GO:0060322~head development	3	13	23.0769230769231	0.00095308321390807	0.0161580851846277	1	1	0.539299889730358	0.987363058278333	0.13359069033909
down	LAMC1; SOX9; TWIST1; OSR1; SMO;	GO:0050679~positive regulation of epithelial cell proliferation	5	57	8.7719298245614	0.00106254394882765	0.0178752585852775	1	1	0.559401189011269	0.987363058278333	0.147787816879986
down	SHH; SMO; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.00114664038276546	0.0189977463417278	1	1	0.574888115780717	0.987363058278333	0.15706824290621
down	MMP2; MMP3; MMP12;	GO:1904645~response to amyloid-beta	3	14	21.4285714285714	0.00114664038276546	0.0189977463417278	1	1	0.574888115780717	0.987363058278333	0.15706824290621
down	CXCL11; CXCL14; CXCL10; FOSL1; CXCL9; CCL26; CXCR1;	GO:0006935~chemotaxis	7	122	5.73770491803279	0.00121475827867512	0.0199750101914473	1	1	0.58764229921787	0.987363058278333	0.165147996839657
down	HRH1; ANO1; ADRA1D; VIP; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	5	60	8.33333333333333	0.00131550088607502	0.0211544149841622	1	1	0.606360244354802	0.987363058278333	0.174898997570729
down	NKX2-8; KRT4; SOX9; ISL1; A4GNT;	GO:0050680~negative regulation of epithelial cell proliferation	5	60	8.33333333333333	0.00131550088607502	0.0211544149841622	1	1	0.606360244354802	0.987363058278333	0.174898997570729
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.00136328474188629	0.0212939994505964	1	1	0.614841418590719	0.987363058278333	0.176053044292137
down	SERPINB5; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.00136328474188629	0.0212939994505964	1	1	0.614841418590719	0.987363058278333	0.176053044292137
down	CCK; CSF3; GHR; IL11; CNTN1; CSPG4;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	6	92	6.52173913043478	0.00145648196137071	0.0212939994505964	1	1	0.625508570025125	0.987363058278333	0.176053044292137
down	WNT9A; SHH; DCDC2; SMO;	GO:0045880~positive regulation of smoothened signaling pathway	4	36	11.1111111111111	0.00152492078661559	0.0213782164123609	1	1	0.631723573456867	0.987363058278333	0.176749327418004
down	FGF1; CSF3; FGF5; F3; MST1R; MEIS3; C1QTNF1; NOX4;	GO:0051897~positive regulation of protein kinase B signaling	8	165	4.84848484848485	0.00155703896802695	0.0216894536501588	1	1	0.634825830444104	0.987363058278333	0.179322552956895
down	GLI2; FOXF2; STRA6;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.00160398706466081	0.0217883211826906	1	1	0.639022322329584	0.987363058278333	0.180139963050487
down	ISL1; SIX1; DMRTA2;	GO:0048665~neuron fate specification	3	16	18.75	0.00160398706466081	0.0217883211826906	1	1	0.639022322329584	0.987363058278333	0.180139963050487
down	SAA1; KRT20; RHBDF1;	GO:0050708~regulation of protein secretion	3	16	18.75	0.00160398706466081	0.0217883211826906	1	1	0.639022322329584	0.987363058278333	0.180139963050487
down	CSMD3; RAB17; MARK1;	GO:0050773~regulation of dendrite development	3	16	18.75	0.00160398706466081	0.0217883211826906	1	1	0.639022322329584	0.987363058278333	0.180139963050487
down	GLI2; BMP2; SOX9; OSR1;	GO:0002062~chondrocyte differentiation	4	37	10.8108108108108	0.00167329106204861	0.0225894293376562	1	1	0.645537510789733	0.987363058278333	0.186763309210337
down	FGF1; F3; ISL1; TWIST1; CCBE1; GATA6; ANGPTL4;	GO:0045766~positive regulation of angiogenesis	7	131	5.34351145038168	0.0017899639931831	0.0240162653563892	1	1	0.656167746954221	0.987363058278333	0.198560004583905
down	KRT16; SERPINB5; SOX9;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.00186967096919177	0.0246323518651952	1	1	0.663672944710538	0.987363058278333	0.203653641675155
down	SLC16A2; SLC5A5; DUOX2;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.00186967096919177	0.0246323518651952	1	1	0.663672944710538	0.987363058278333	0.203653641675155
down	APOC1; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	3	17	17.6470588235294	0.00186967096919177	0.0246323518651952	1	1	0.663672944710538	0.987363058278333	0.203653641675155
down	NHLH2; SHH; KLK6; SMO; SOX9; TBX3; SPINK6;	GO:0007417~central nervous system development	7	133	5.26315789473684	0.00194251344343677	0.025438783837103	1	1	0.670167137985684	0.987363058278333	0.210321003717607
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.00209115360270229	0.815835016247462	1	1	0.999999999999999	0.999999999999999	1
down	CTSE; SHH; KLK6;	GO:0016540~protein autoprocessing	3	18	16.6666666666667	0.00216121417917847	0.0262567184303566	1	1	0.690075550121558	0.987363058278333	0.217083466330994
down	KRT20; KRT17; SHH;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00216121417917847	0.0262567184303566	1	1	0.690075550121558	0.987363058278333	0.217083466330994
down	TSPAN15; SERPINH1; DUOXA2;	GO:0051604~protein maturation	3	18	16.6666666666667	0.00216121417917847	0.0262567184303566	1	1	0.690075550121558	0.987363058278333	0.217083466330994
down	ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.00216121417917847	0.0262567184303566	1	1	0.690075550121558	0.987363058278333	0.217083466330994
down	BMP2; SOX9; FOXF2; LOXL2;	GO:0001837~epithelial to mesenchymal transition	4	40	10	0.00217806759691408	0.0262567184303566	1	1	0.691831273313239	0.987363058278333	0.217083466330994
down	COL4A1; ANXA4; KRT4; SIX1; GATA6;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.00220549171421758	0.0262567184303566	1	1	0.694523907087028	0.987363058278333	0.217083466330994
up	F13A1; CSTA; ANXA1; DSP; TGM1; EVPL; TGM4; TGM5; EPB42;	GO:0018149~peptide cross-linking	9	27	33.3333333333333	0.00231698174383943	0.815835016247462	1	1	0.999999999999999	0.999999999999999	1
down	CLDN1; CYP1A1; IDO1; PTGFR; LOXL1; NOS1; NOS2;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.00236801511592744	0.0275470694602835	1	1	0.709152157877322	0.987363058278333	0.227751740628228
down	DLX2; DLX1; OSR1;	GO:0009790~embryo development	3	19	15.7894736842105	0.00247944975747616	0.0281406922765685	1	1	0.719040429668086	0.987363058278333	0.232659653968356
down	PLTP; CAV1; ABCA12;	GO:0010875~positive regulation of cholesterol efflux	3	19	15.7894736842105	0.00247944975747616	0.0281406922765685	1	1	0.719040429668086	0.987363058278333	0.232659653968356
down	TBX3; SHH; LGR4;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.00247944975747616	0.0281406922765685	1	1	0.719040429668086	0.987363058278333	0.232659653968356
down	WNT9A; WNT7B; SHH; FZD8; FZD10;	GO:0060070~canonical Wnt signaling pathway	5	70	7.14285714285714	0.00248338070844889	0.0281406922765685	1	1	0.719570076102729	0.987363058278333	0.232659653968356
down	CXCL11; CXCL10; CXCR1; CCL26; CXCL9;	GO:0070098~chemokine-mediated signaling pathway	5	70	7.14285714285714	0.00248338070844889	0.0281406922765685	1	1	0.719570076102729	0.987363058278333	0.232659653968356
down	STEAP2; FOXC2; NOS1; NOS2;	GO:0009725~response to hormone	4	42	9.52380952380952	0.00256749650856303	0.0289438910527183	1	1	0.726062347127493	0.987363058278333	0.239300284820298
down	CYP1A1; EDNRA; CSPG4; FAM83A; RHBDF1; PAK5; LIPG;	GO:0008283~cell population proliferation	7	142	4.92957746478873	0.00275733311872739	0.0308514339008591	1	1	0.740467073463687	0.987363058278333	0.255071334608857
down	GJC1; CDH11; CDH18; CDH10;	GO:0007043~cell-cell junction assembly	4	43	9.30232558139535	0.00277902719637368	0.0308514339008591	1	1	0.742000261431774	0.987363058278333	0.255071334608857
down	EFNB2; CDH11; CDH18; CDH10;	GO:0034332~adherens junction organization	4	43	9.30232558139535	0.00277902719637368	0.0308514339008591	1	1	0.742000261431774	0.987363058278333	0.255071334608857
down	COL11A1; SOX9; ALX1;	GO:0001502~cartilage condensation	3	20	15	0.00282516731366045	0.030893204574877	1	1	0.745844170806358	0.987363058278333	0.255416683275745
down	NKX3-2; SIX1; OSR1;	GO:0042474~middle ear morphogenesis	3	20	15	0.00282516731366045	0.030893204574877	1	1	0.745844170806358	0.987363058278333	0.255416683275745
down	COL4A1; NR2F2; EFNB2;	GO:0048514~blood vessel morphogenesis	3	20	15	0.00282516731366045	0.030893204574877	1	1	0.745844170806358	0.987363058278333	0.255416683275745
down	BMP2; TNC; MSX2; TWIST1; SMO; LGR4;	GO:0001649~osteoblast differentiation	6	106	5.66037735849057	0.00286188069779869	0.031138970577541	1	1	0.747857950778031	0.987363058278333	0.257448610300675
down	PTHLH; BMP2; LGR4; TUFT1;	GO:0030282~bone mineralization	4	44	9.09090909090909	0.00300218060645063	0.0321573196040229	1	1	0.755279441892622	0.987363058278333	0.265868045394586
down	EDNRA; SOX9; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.00319911418544927	0.0323910311276739	1	1	0.7652273980675	0.987363058278333	0.267800309238227
down	BMP2; GATA6; NOX4;	GO:0055007~cardiac muscle cell differentiation	3	21	14.2857142857143	0.00319911418544927	0.0323910311276739	1	1	0.7652273980675	0.987363058278333	0.267800309238227
down	SHH; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	3	21	14.2857142857143	0.00319911418544927	0.0323910311276739	1	1	0.7652273980675	0.987363058278333	0.267800309238227
down	CPE; RAB38; FERMT2;	GO:0072657~protein localization to membrane	3	21	14.2857142857143	0.00319911418544927	0.0323910311276739	1	1	0.7652273980675	0.987363058278333	0.267800309238227
down	MUC21; DSCAM; TNC; DACT2;	GO:0007162~negative regulation of cell adhesion	4	45	8.88888888888889	0.0032372613884073	0.032626224223257	1	1	0.76723094905253	0.987363058278333	0.269744822319011
down	GPR37; ALOX12B; BMP2; IL11; ADRA1B; C1QTNF1;	GO:0043410~positive regulation of MAPK cascade	6	109	5.5045871559633	0.00326274182790509	0.0327321852184791	1	1	0.768831730014919	0.987363058278333	0.270620879248963
down	CXCL14; BMP2; SHH; SIX1;	GO:0048839~inner ear development	4	46	8.69565217391304	0.00348457052517115	0.0347979714089009	1	1	0.780543797638337	0.987363058278333	0.28770024231198
down	LHX1; SIM2; SHH;	GO:0009880~embryonic pattern specification	3	22	13.6363636363636	0.00360199659453175	0.0356450975214522	1	1	0.786076408014848	0.987363058278333	0.29470405253373
down	KRT18; KRT16; KRT6C;	GO:0045104~intermediate filament cytoskeleton organization	3	22	13.6363636363636	0.00360199659453175	0.0356450975214522	1	1	0.786076408014848	0.987363058278333	0.29470405253373
down	SCNN1G; FXYD3; SLC4A11; SLC5A5; SLC6A15;	GO:0006814~sodium ion transport	5	77	6.49350649350649	0.00365734941835894	0.0360298341349144	1	1	0.789490705811103	0.987363058278333	0.297884951087231
down	SAA1; EDNRA; C1QTNF1; ADRA1D; ADRA1B; PTGFR; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	7	150	4.66666666666667	0.00368142167957486	0.0361043462476691	1	1	0.790656733892851	0.987363058278333	0.298500997138962
up	F2; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-1; IGKC; IGHG2; IGHG3; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; CD19;	GO:0030449~regulation of complement activation	21	113	18.5840707964602	0.00378776086197585	0.913902462462103	1	1	0.999999999999999	0.999999999999999	1
up	TGM5; PPL; CSTA; KRT3; DSP; TGM1; DSG3; DSC2; PKP1; PRSS8; LIPN; KRT79; KRT80; KRT73; CERS3; KRT78; EVPL; PERP; TMEM79; SPINK5; PKP3;	GO:0070268~cornification	21	113	18.5840707964602	0.00378776086197585	0.913902462462103	1	1	0.999999999999999	0.999999999999999	1
down	NKX2-8; CCK; S100A6; SLITRK6; ISL1;	GO:0007409~axonogenesis	5	78	6.41025641025641	0.00385264274044217	0.0375623343471402	1	1	0.799237504648277	0.987363058278333	0.310555249514103
up	F2; JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-1; IGKC; IGHA2; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; THBD; DBH; CD48; IGLC2; IGLC3; SELE; SDC4; CEACAM3; CEACAM6; GRB7; ANGPT1; SIRPG; CD84;	GO:0050900~leukocyte migration	31	193	16.0621761658031	0.00386357811251081	0.913902462462103	1	1	0.999999999999999	0.999999999999999	1
down	KRT18; SOX9; CRNN; CDH10; CDH11; COL16A1; CDH18;	GO:0098609~cell-cell adhesion	7	152	4.60526315789474	0.00394539118240389	0.0375623343471402	1	1	0.804495646126226	0.987363058278333	0.310555249514103
down	NTF4; GDNF; SLITRK6; FOXA2;	GO:0008344~adult locomotory behavior	4	48	8.33333333333333	0.00401705831092214	0.0375623343471402	1	1	0.80742872049535	0.987363058278333	0.310555249514103
down	SHH; DMRTA2; SMO;	GO:0002052~positive regulation of neuroblast proliferation	3	23	13.0434782608696	0.00403448077765389	0.0375623343471402	1	1	0.808624522320321	0.987363058278333	0.310555249514103
up	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-1; IGKC; IGHG2; IGHG3; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; TRDC; IGHV5-51; IGHV3-35; IGHD; TRBC2; TRBC1; IGHV3-74; IGHA2;	GO:0006958~complement activation, classical pathway	27	161	16.7701863354037	0.00403743593388117	0.913902462462103	1	1	0.999999999999999	0.999999999999999	1
down	CXCL10; CXCL11; CXCL9;	GO:0030595~leukocyte chemotaxis	3	24	12.5	0.00449719409312777	0.0403088667281575	1	1	0.832042029092796	0.987363058278333	0.333262838478161
down	ISL1; NKX3-2; SHH;	GO:0031016~pancreas development	3	24	12.5	0.00449719409312777	0.0403088667281575	1	1	0.832042029092796	0.987363058278333	0.333262838478161
down	ONECUT2; SOX9; FOXA2;	GO:0031018~endocrine pancreas development	3	24	12.5	0.00449719409312777	0.0403088667281575	1	1	0.832042029092796	0.987363058278333	0.333262838478161
down	GLI2; SOX9; SIX1;	GO:0090103~cochlea morphogenesis	3	24	12.5	0.00449719409312777	0.0403088667281575	1	1	0.832042029092796	0.987363058278333	0.333262838478161
down	COL4A1; COL5A2; MMP2; COL16A1;	GO:0071230~cellular response to amino acid stimulus	4	51	7.84313725490196	0.00491479575776177	0.0438720747845918	1	1	0.845344870335024	0.987363058278333	0.362722481662474
down	HNF4A; CAV1; MALL; LIPG; CYP39A1;	GO:0042632~cholesterol homeostasis	5	83	6.02409638554217	0.00494231150255642	0.0439383546995564	1	1	0.845482705666314	0.987363058278333	0.363270466123168
down	ALDH1A3; CYP27C1; CYP2S1;	GO:0042573~retinoic acid metabolic process	3	25	12	0.00499072610353601	0.0440434086472879	1	1	0.847098792392659	0.987363058278333	0.364139023829104
down	NR2F2; HNF4A; HNF4G; NR0B2;	GO:0043401~steroid hormone mediated signaling pathway	4	52	7.69230769230769	0.00524156724857916	0.0440434086472879	1	1	0.853121331416018	0.987363058278333	0.364139023829104
down	FOSL1; CXCL9; LGALS3BP; DCDC2;	GO:0006968~cellular defense response	4	53	7.54716981132075	0.00558255633672045	0.0464222460395727	1	1	0.860792351676959	0.987363058278333	0.383806609796661
down	FGF1; BCAR1; CCBE1; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	4	54	7.40740740740741	0.00593802854577541	0.0490055412438144	1	1	0.869461228232006	0.987363058278333	0.405164597809538
down	ARTN; NTF4; GDNF;	GO:0007422~peripheral nervous system development	3	27	11.1111111111111	0.00607242180879841	0.0497392752653263	1	1	0.873010049571729	0.987363058278333	0.411230912805346
down	CDH18; CDH11; CDH10;	GO:0044331~cell-cell adhesion mediated by cadherin	3	27	11.1111111111111	0.00607242180879841	0.0497392752653263	1	1	0.873010049571729	0.987363058278333	0.411230912805346
down	KCNU1; KCNK2; LRRC38; NALCN; KCNS3; KCNF1;	GO:0071805~potassium ion transmembrane transport	6	125	4.8	0.00614128515307688	0.0501156366782804	1	1	0.874232752722389	0.987363058278333	0.414342567459906
down	NOX4; CDH18; CAP2; CDH11; CDH10;	GO:0000902~cell morphogenesis	5	88	5.68181818181818	0.00623421017765258	0.050684824009391	1	1	0.875213944783297	0.987363058278333	0.419048454799061
down	F3; MMP16; KLK13; CPE;	GO:0016485~protein processing	4	55	7.27272727272727	0.00630824434112842	0.0510967791631402	1	1	0.876073402012217	0.987363058278333	0.422454388902594
up	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-1; IGKC; IGHG2; IGHG3; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; FCGR2A; FCGR2B; NCKAP1L;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	23	135	17.037037037037	0.00639595950032723	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	MSX2; ISL1; GATA6;	GO:0003148~outflow tract septum morphogenesis	3	28	10.7142857142857	0.00666158506386405	0.0518465712977604	1	1	0.879301607213526	0.987363058278333	0.428653468046577
down	SLIT3; SOX9; TWIST1;	GO:0003180~aortic valve morphogenesis	3	28	10.7142857142857	0.00666158506386405	0.0518465712977604	1	1	0.879301607213526	0.987363058278333	0.428653468046577
down	CYP1A1; CLDN18; LGR4;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.00666158506386405	0.0518465712977604	1	1	0.879301607213526	0.987363058278333	0.428653468046577
up	APOA2; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.00677694033201148	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	IL2; IL18; IL21; IL23A;	GO:0034105~positive regulation of tissue remodeling	4	6	66.6666666666667	0.00677694033201148	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	SOX15; INHA; SOX9; GATA6; SIX4;	GO:0008584~male gonad development	5	90	5.55555555555556	0.0068116655801912	0.0528266405102062	1	1	0.88029255568146	0.987363058278333	0.436756415962415
down	KCNK2; FOSL1; TNC; POSTN;	GO:0009612~response to mechanical stimulus	4	57	7.01754385964912	0.00709392260403041	0.0546281997711779	1	1	0.882919423387406	0.987363058278333	0.451651222036897
down	COL11A1; ALDH1A3; SIX1; SIX4;	GO:0042472~inner ear morphogenesis	4	57	7.01754385964912	0.00709392260403041	0.0546281997711779	1	1	0.882919423387406	0.987363058278333	0.451651222036897
down	SLC39A12; KLK6; MARK1;	GO:0010975~regulation of neuron projection development	3	29	10.3448275862069	0.00728356813801689	0.0556963759365138	1	1	0.884607127771934	0.987363058278333	0.460482614476067
down	CXCL11; CXCL10; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	3	29	10.3448275862069	0.00728356813801689	0.0556963759365138	1	1	0.884607127771934	0.987363058278333	0.460482614476067
down	APOC1; NR2F2; HNF4A; PLTP; ANGPTL4; LIPG;	GO:0006629~lipid metabolic process	6	130	4.61538461538462	0.00733403627395113	0.0558868896555091	1	1	0.885189787618973	0.987363058278333	0.462057730521616
down	GHR; APLP1; PRSS12; LGALS3BP; SHH; STEAP2; LOXL2;	GO:0006897~endocytosis	7	174	4.02298850574713	0.00788389758850538	0.0578737575349855	1	1	0.890254446289393	0.987363058278333	0.478484618274649
down	CAPN8; CYP39A1; CCK;	GO:0007586~digestion	3	30	10	0.00793878704183615	0.0578737575349855	1	1	0.890254446289393	0.987363058278333	0.478484618274649
down	BCAR1; CSPG4; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	3	30	10	0.00793878704183615	0.0578737575349855	1	1	0.890254446289393	0.987363058278333	0.478484618274649
down	EPCAM; MSX2; OSR1;	GO:0048863~stem cell differentiation	3	30	10	0.00793878704183615	0.0578737575349855	1	1	0.890254446289393	0.987363058278333	0.478484618274649
down	GLI2; LHX1; SIX1; HAS2; STRA6;	GO:0001822~kidney development	5	94	5.31914893617021	0.00807685228084964	0.0584903176762191	1	1	0.89164474474794	0.987363058278333	0.483582171231067
down	AKR7A3; NQO1; AADAC; HNF4A; CYP2S1;	GO:0006805~xenobiotic metabolic process	5	94	5.31914893617021	0.00807685228084964	0.0584903176762191	1	1	0.89164474474794	0.987363058278333	0.483582171231067
down	NR2F2; XDH; CAV1;	GO:0001937~negative regulation of endothelial cell proliferation	3	31	9.67741935483871	0.00862762600543088	0.0622726669104862	1	1	0.896971783052266	0.987363058278333	0.514853614569538
down	LAMC1; BCAR1; DOCK1; SYDE1; MISP; RHBDF1; PAK5; GPC6;	GO:0016477~cell migration	8	225	3.55555555555556	0.00926801174487413	0.0646543658160104	1	1	0.902204764500497	0.987363058278333	0.534544858756785
down	KLK8; CYP1A1; TNC; KLK6;	GO:0009611~response to wounding	4	62	6.45161290322581	0.00933334452542178	0.0646543658160104	1	1	0.90314630472319	0.987363058278333	0.534544858756785
down	KLK8; WNT7B; NYAP1; NTF4;	GO:0048812~neuron projection morphogenesis	4	62	6.45161290322581	0.00933334452542178	0.0646543658160104	1	1	0.90314630472319	0.987363058278333	0.534544858756785
down	THBS2; TPBG; SLITRK6; ADGRL3;	GO:0051965~positive regulation of synapse assembly	4	62	6.45161290322581	0.00933334452542178	0.0646543658160104	1	1	0.90314630472319	0.987363058278333	0.534544858756785
down	SLC6A15; SLC6A14; SLC6A5;	GO:0006810~transport	3	32	9.375	0.00935043840519767	0.0646543658160104	1	1	0.90314630472319	0.987363058278333	0.534544858756785
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00961435870967353	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	AKR1B10; RBP1; STRA6; GPC6;	GO:0001523~retinoid metabolic process	4	63	6.34920634920635	0.00983024570749391	0.0669742908482529	1	1	0.90713664185746	0.987363058278333	0.553725373220656
down	SHH; SMO; NDRG4; TBX3;	GO:0001947~heart looping	4	63	6.34920634920635	0.00983024570749391	0.0669742908482529	1	1	0.90713664185746	0.987363058278333	0.553725373220656
down	CXCL10; FGF1; ANO1; SLC52A3;	GO:0034605~cellular response to heat	4	63	6.34920634920635	0.00983024570749391	0.0669742908482529	1	1	0.90713664185746	0.987363058278333	0.553725373220656
down	TWIST1; OSR1; TUFT1;	GO:0042476~odontogenesis	3	33	9.09090909090909	0.0101075476698418	0.0682259467714321	1	1	0.909679290285761	0.987363058278333	0.564073726811686
down	HOXD8; HOXC8; NKX3-2;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.0101075476698418	0.0682259467714321	1	1	0.909679290285761	0.987363058278333	0.564073726811686
down	NOS1; HES7; HES2;	GO:0050767~regulation of neurogenesis	3	33	9.09090909090909	0.0101075476698418	0.0682259467714321	1	1	0.909679290285761	0.987363058278333	0.564073726811686
down	CLDN1; CSF3; NQO1; TNC; CLDN18;	GO:0045471~response to ethanol	5	100	5	0.0102666759313311	0.0690868315748344	1	1	0.911526012705158	0.987363058278333	0.571191290178561
down	DLX1; DLX2; CDK5R2; LHX5;	GO:0021766~hippocampus development	4	64	6.25	0.0103439912249724	0.0693935853037261	1	1	0.911526012705158	0.987363058278333	0.573727447275054
down	FGF1; MMP2; COL4A2; CAV1; CSPG4; ANGPTL4; FZD8; TMEM100;	GO:0001525~angiogenesis	8	230	3.47826086956522	0.0104429983111897	0.0698435391638281	1	1	0.912692807487457	0.987363058278333	0.57744754443415
down	PLTP; ABCA12; SLCO2A1; CAV1;	GO:0006869~lipid transport	4	65	6.15384615384615	0.0108747860738034	0.0715111933999436	1	1	0.916377422589455	0.987363058278333	0.591235259878399
down	GLI2; SHH; DZIP1; SMO;	GO:0007224~smoothened signaling pathway	4	65	6.15384615384615	0.0108747860738034	0.0715111933999436	1	1	0.916377422589455	0.987363058278333	0.591235259878399
down	RBFOX2; DSCAM; DCDC2;	GO:0048813~dendrite morphogenesis	3	34	8.82352941176471	0.0108992481664407	0.0715111933999436	1	1	0.916377422589455	0.987363058278333	0.591235259878399
down	COL11A1; ALDH7A1; SIX1; SLITRK6; SLC52A3; DCDC2;	GO:0007605~sensory perception of sound	6	143	4.1958041958042	0.0112052801140989	0.0725028035785041	1	1	0.918999806310696	0.987363058278333	0.599433625389381
up	CES2; PTGES; HPGDS; HPGD; AKR1C2; AKR1C4;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.0122569193207591	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	ROS1; BCAR1; PAPPA2; PAK5;	GO:0001558~regulation of cell growth	4	69	5.79710144927536	0.0131723518783553	0.0806944917590001	1	1	0.936399114175443	0.987363058278333	0.667160293900582
down	HOXC13; SOX9; LGR4;	GO:0001942~hair follicle development	3	37	8.10810810810811	0.0134844228475804	0.0821460522776001	1	1	0.940236815463047	0.987363058278333	0.679161404770651
down	FXYD3; ANO4; ANO1;	GO:0006821~chloride transport	3	37	8.10810810810811	0.0134844228475804	0.0821460522776001	1	1	0.940236815463047	0.987363058278333	0.679161404770651
down	CSF3; BMP2; CAV1; PLK2;	GO:0032092~positive regulation of protein binding	4	70	5.71428571428571	0.0137912610387128	0.08378191081018	1	1	0.942251608639039	0.987363058278333	0.692686241913628
up	JCHAIN; IGKV3-20; IGHA2; LTF; DEFA3; DEFB1; RNASE6; RNASE7;	GO:0019731~antibacterial humoral response	8	31	25.8064516129032	0.0139167328133099	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	RBP1; HNF4A; ABCA12;	GO:0055088~lipid homeostasis	3	38	7.89473684210526	0.0144168806200693	0.0846496655189031	1	1	0.948720155151435	0.987363058278333	0.699860603804826
down	CDH11; GRIK2; PLCB4; NTF4;	GO:0050804~modulation of chemical synaptic transmission	4	71	5.63380281690141	0.0144283247194115	0.0846496655189031	1	1	0.948720155151435	0.987363058278333	0.699860603804826
down	MST1R; CXCL9; DUOX2; NOX4;	GO:0006952~defense response	4	72	5.55555555555556	0.0150837060849799	0.0872700137773836	1	1	0.953424552614996	0.987363058278333	0.721524936476638
down	CNTN1; DPYSL3; PLPPR5; TENM3; NDRG4;	GO:0010976~positive regulation of neuron projection development	5	111	4.5045045045045	0.0152751079340263	0.0879122659255672	1	1	0.955907429054098	0.987363058278333	0.726834904017175
down	CLCA1; KCNK2; STC1; TWIST1; GATA6;	GO:0071456~cellular response to hypoxia	5	111	4.5045045045045	0.0152751079340263	0.0879122659255672	1	1	0.955907429054098	0.987363058278333	0.726834904017175
down	SHH; ALX1; HOXC10;	GO:0030326~embryonic limb morphogenesis	3	39	7.69230769230769	0.0153849951793974	0.0883122951636276	1	1	0.955907429054098	0.987363058278333	0.730142237866308
down	BMP2; F3; CCL26; VIP;	GO:0001938~positive regulation of endothelial cell proliferation	4	73	5.47945205479452	0.0157575622530296	0.0902141064067428	1	1	0.961159667675274	0.987363058278333	0.745865900290375
up	PLD1; TNFAIP8L3; ADAP2;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.0157854697000007	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.0157854697000007	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	CCR6; SPNS2; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0157854697000007	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0157854697000007	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	GJC1; GRIK2; GPR176; SNCB; PCDHB10; SLC6A5; PCDHB4; HRH1;	GO:0007268~chemical synaptic transmission	8	249	3.21285140562249	0.0159278820896771	0.0909511178332215	1	1	0.961159667675274	0.987363058278333	0.751959311986506
down	EDNRA; CAP2; LGR4;	GO:0007190~activation of adenylate cyclase activity	3	40	7.5	0.0163889040457854	0.0922809760262352	1	1	0.965411539120408	0.987363058278333	0.762954220852738
down	KRT8; KRT19; SIX4;	GO:0045214~sarcomere organization	3	40	7.5	0.0163889040457854	0.0922809760262352	1	1	0.965411539120408	0.987363058278333	0.762954220852738
down	SLIT3; ROS1; BMP2; NOS2; XDH; NR0B2; SMO;	GO:0010629~negative regulation of gene expression	7	204	3.43137254901961	0.0171447261828616	0.0954084380710387	1	1	0.969261634989283	0.987363058278333	0.788811233537143
up	CCL24; LGALS3; CCL7; XCL2; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	6	20	30	0.018165985234416	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGLC3; IGHV3-35; TRBC2; IGHV5-51; CD79B; IGHG2; IGHG3; TRBC1; IGHA2; IGHV3-74; TRDC; IGHD; IGLC2; IGKC;	GO:0050853~B cell receptor signaling pathway	20	125	16	0.0182223740788346	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; TRDV2; LILRA5; CD300LB; TYROBP; LY86; JCHAIN; TRGV3; ANXA1; S100B; LGALS3; KIR2DS4; NLRP6; LILRA4; DEFB1; S100A12; SIGLEC14; NAIP; SLAMF1; TRIM29; CD300E; CLEC6A; TREML4; NLRP9; CLEC10A; ZNF683; LILRA2; DEFB108B; CLEC4C; RNASE6; PLD4; SIGLEC10; PGLYRP2; CD180; TRGV9; RNASE7; CD209; IL23A; DDX21; TLR8; LYAR; TLR7; CD84; CLEC4A; TRDC; IGHV3-35; TRBC1; TRBC2; IGLC3; IGHV5-51; IGHA2; IGLC2; IGHV3-74; IGHG3; IGHV4-34; IGKC; IGHD; IGHG2;	GO:0045087~innate immune response	62	505	12.2772277227723	0.0184756647490038	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	TSPAN15; DLX1; DLX2;	GO:0045746~negative regulation of Notch signaling pathway	3	42	7.14285714285714	0.0185045385553333	0.096270700869745	1	1	0.977944829927597	0.987363058278333	0.795940189797534
down	GPX8; CYGB; PXDN; DUOX2;	GO:0098869~cellular oxidant detoxification	4	77	5.19480519480519	0.0186406654871439	0.096270700869745	1	1	0.977944829927597	0.987363058278333	0.795940189797534
down	CXCL10; CSF2; CSF3; NOS2; CXCL11; CXCL9;	GO:0071222~cellular response to lipopolysaccharide	6	163	3.68098159509202	0.0196780286253911	0.096270700869745	1	1	0.983901431269557	0.987363058278333	0.795940189797534
up	HP; HPR; JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-1; IGKC; IGHA2; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; FCGR2B; FCGR1B; STAB1;	GO:0006898~receptor-mediated endocytosis	24	160	15	0.0197549640313589	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	FRK; BCAR1; NTF4; MST1R; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	5	120	4.16666666666667	0.0204187477100818	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	SHH; SIX1; SIX4;	GO:0048538~thymus development	3	44	6.81818181818182	0.020764429619668	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	IL33; KRT18; KRT8;	GO:0097191~extrinsic apoptotic signaling pathway	3	44	6.81818181818182	0.020764429619668	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	PTHLH; TSPAN8; GDNF; LHX1; CRNN; SHH;	GO:0010468~regulation of gene expression	6	166	3.6144578313253	0.0212434350775388	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	FGF1; SAA1; GHR; BMP2; CSPG4;	GO:0000187~activation of MAPK activity	5	122	4.0983606557377	0.0216977206332511	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	CYP1A1; GLI2; BMP2;	GO:0071407~cellular response to organic cyclic compound	3	45	6.66666666666667	0.0219485795540454	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	FGF1; TNC; EPB41L4B; SPRR3;	GO:0042060~wound healing	4	82	4.8780487804878	0.0226765656864648	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	TBX3; ISL1; SIX1;	GO:0003151~outflow tract morphogenesis	3	46	6.52173913043478	0.0231688829126846	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	CXCL10; SAA1; SAA2;	GO:0050918~positive chemotaxis	3	46	6.52173913043478	0.0231688829126846	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
up	FCGR2B; ZPBP2; FCRL3;	GO:0002638~negative regulation of immunoglobulin production	3	5	60	0.0237034183617275	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0237034183617275	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	IL10; IL18; BCL6B;	GO:0042092~type 2 immune response	3	5	60	0.0237034183617275	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	CCK; HRH1; NDRG4;	GO:0008542~visual learning	3	47	6.38297872340426	0.0244253283841604	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	GLI2; DPYSL3; TENM3;	GO:0048666~neuron development	3	47	6.38297872340426	0.0244253283841604	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	FGF1; FGF5; SHH;	GO:0051781~positive regulation of cell division	3	47	6.38297872340426	0.0244253283841604	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	FOXC2; LGR4; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	3	47	6.38297872340426	0.0244253283841604	0.096270700869745	1	1	0.987363058278333	0.987363058278333	0.795940189797534
down	LHX1; CNTN1; CDK5R2;	GO:0021549~cerebellum development	3	48	6.25	0.0257178860869979	0.0985026565188518	1	1	0.987363058278333	0.987363058278333	0.814393397127699
down	PTHLH; IDO1; FOSL1; COL16A1;	GO:0007565~female pregnancy	4	86	4.65116279069767	0.0262594015453932	0.100225673961213	1	1	0.987363058278333	0.987363058278333	0.828638840629277
down	EFNA2; MMP2; EFNB2; EFNB3;	GO:0048013~ephrin receptor signaling pathway	4	86	4.65116279069767	0.0262594015453932	0.100225673961213	1	1	0.987363058278333	0.987363058278333	0.828638840629277
up	ALOX15B; TRIM16; FOXC1; OVOL2; IL20;	GO:0045618~positive regulation of keratinocyte differentiation	5	16	31.25	0.0266425312664478	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	KLK8; WNT7B; SNCB;	GO:0050808~synapse organization	3	49	6.12244897959184	0.0270465081957399	0.103050023386905	1	1	0.987363058278333	0.987363058278333	0.851989799930813
up	IL2RA; CTLA4; IL10; SDC4; IL20RB; LILRB2; LILRB1; GLMN; CD80;	GO:0042130~negative regulation of T cell proliferation	9	43	20.9302325581395	0.0271596707002782	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	ASTN1; DSCAM; ALDH1A3; PAK5;	GO:0007626~locomotory behavior	4	87	4.59770114942529	0.0272050286169723	0.103473734930988	1	1	0.987363058278333	0.987363058278333	0.855492932698837
down	CSF3; IL11; NOS1; CAV1;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	4	88	4.54545454545455	0.0281707673935055	0.105676617992447	1	1	0.987363058278333	0.987363058278333	0.873705775715442
down	BMP2; IGFBP6; SOX9; ISL1; CAV1; SHH;	GO:0090090~negative regulation of canonical Wnt signaling pathway	6	179	3.35195530726257	0.0289959176971631	0.108585739732356	1	1	0.987363058278333	0.987363058278333	0.897757609647138
down	CXCL10; COL4A2; THBS2; PLK2;	GO:0016525~negative regulation of angiogenesis	4	89	4.49438202247191	0.0291566800772239	0.109001127057929	1	1	0.987363058278333	0.987363058278333	0.90119192002163
down	CSF3; CDC42EP5; CCL26;	GO:0030838~positive regulation of actin filament polymerization	3	51	5.88235294117647	0.0298116682680512	0.111070048555754	1	1	0.987363058278333	0.987363058278333	0.918297204960638
down	VIP; SIX1; SIX4;	GO:0032880~regulation of protein localization	3	51	5.88235294117647	0.0298116682680512	0.111070048555754	1	1	0.987363058278333	0.987363058278333	0.918297204960638
up	IL2RA; CD24; IL2; IL18; IL23A; HHLA2;	GO:0042104~positive regulation of activated T cell proliferation	6	23	26.0869565217391	0.030265790572449	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	ANXA4; NQO1; SNCB;	GO:0043086~negative regulation of catalytic activity	3	52	5.76923076923077	0.0312480262974477	0.11155301573491	1	1	0.987363058278333	0.987363058278333	0.922290247337706
up	CCL21; TRPM2; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.0321707263929368	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	BMP2; NOS2; CAV1; FER1L6;	GO:0009617~response to bacterium	4	92	4.34782608695652	0.0322359989743428	0.11155301573491	1	1	0.987363058278333	0.987363058278333	0.922290247337706
down	EFNB2; CAV1; EFNB3;	GO:0031295~T cell costimulation	3	53	5.66037735849057	0.0327200900172817	0.11155301573491	1	1	0.987363058278333	0.987363058278333	0.922290247337706
down	CSF3; DPYSL3; CRNN;	GO:0071345~cellular response to cytokine stimulus	3	53	5.66037735849057	0.0327200900172817	0.11155301573491	1	1	0.987363058278333	0.987363058278333	0.922290247337706
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0333788891952431	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.0333788891952431	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0333788891952431	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.0333788891952431	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0333788891952431	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0333788891952431	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	STC1; SLC5A5; NOX4;	GO:0071320~cellular response to cAMP	3	54	5.55555555555556	0.0342277307773677	0.11155301573491	1	1	0.987363058278333	0.987363058278333	0.922290247337706
up	PF4; IL10; IRF8; IRF4; BATF; GBP7;	GO:0042832~defense response to protozoan	6	24	25	0.0352413445734733	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	EREG; EGFR; ERBB3; BTC; MATK; PTK6; GRB7;	GO:0038128~ERBB2 signaling pathway	7	31	22.5806451612903	0.0358978613946138	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	BCAR1; COL16A1; DOCK1; FERMT2;	GO:0007229~integrin-mediated signaling pathway	4	96	4.16666666666667	0.036626986760407	0.11155301573491	1	1	0.987363058278333	0.987363058278333	0.922290247337706
down	CLCA1; FXYD3; ANO4; ANO1;	GO:1902476~chloride transmembrane transport	4	97	4.12371134020619	0.0377758610235341	0.113952838701337	1	1	0.987363058278333	0.987363058278333	0.942131336372289
up	SPI1; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	5	18	27.7777777777778	0.0383631432239725	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	ALOX15B; MT1G; MT1H; MT1X; PTK6;	GO:0045926~negative regulation of growth	5	18	27.7777777777778	0.0383631432239725	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	PLPP2; GATA6; PLPPR5;	GO:0006644~phospholipid metabolic process	3	57	5.26315789473684	0.0389626147171203	0.116568041568183	1	1	0.987363058278333	0.987363058278333	0.963753128333825
up	IL2RA; CTLA4; FCGR2B; SPINK5;	GO:0050777~negative regulation of immune response	4	12	33.3333333333333	0.0392383777999746	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	TRPM2; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	4	12	33.3333333333333	0.0392383777999746	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	GPR37; EDNRA; GPR176;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	3	59	5.08474576271187	0.0422941029162875	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
down	BMP2; HNF4A; INHA;	GO:0060395~SMAD protein signal transduction	3	59	5.08474576271187	0.0422941029162875	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
down	NQO1; CYGB; PXDN; DUOX2;	GO:0006979~response to oxidative stress	4	102	3.92156862745098	0.0438275893199088	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
down	FGF1; MST1R; NOX4;	GO:0043406~positive regulation of MAP kinase activity	3	60	5	0.0440117295788429	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
down	BMP2; MSX2; WNT7B;	GO:0045669~positive regulation of osteoblast differentiation	3	60	5	0.0440117295788429	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
up	ALOX15B; PRLR; CD24;	GO:0030856~regulation of epithelial cell differentiation	3	7	42.8571428571429	0.0447797244223525	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.0447797244223525	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0447797244223525	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	IFNG; PAX6; FOXC1;	GO:1904798~positive regulation of core promoter binding	3	7	42.8571428571429	0.0447797244223525	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	NQO1; NR2F2; PTGFR; POSTN;	GO:0032355~response to estradiol	4	103	3.88349514563107	0.0450993909434996	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
up	CCL22; XCL2; CCL8; CCL2; CCL24; CCL21; CCL7;	GO:0048247~lymphocyte chemotaxis	7	33	21.2121212121212	0.0459143357151824	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	CYP1A1; FOSL1; MST1R; DUOX2;	GO:0009615~response to virus	4	104	3.84615384615385	0.0463916495768812	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
down	FOSL1; STRA6; PAK5;	GO:0007612~learning	3	62	4.83870967741935	0.0475496517487097	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
down	KRT19; CAV1; GATA6;	GO:0043627~response to estrogen	3	62	4.83870967741935	0.0475496517487097	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
down	CXCL9; CXCL10; CXCL11;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	3	62	4.83870967741935	0.0475496517487097	0.123408193599237	1	1	0.987363058278333	0.987363058278333	1
up	CRYBA1; IL10; CLEC4A; NDRG2;	GO:0001818~negative regulation of cytokine production	4	13	30.7692307692308	0.0480164360182243	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
up	PTGES; APOA2; HP; HPR;	GO:0002526~acute inflammatory response	4	13	30.7692307692308	0.0480164360182243	0.947817168686333	1	1	0.999999999999999	0.999999999999999	1
down	GJC1; MYL7; CALD1; NOS1;	GO:0006936~muscle contraction	4	106	3.77358490566038	0.0490374458245929	0.123696532893177	1	1	0.987363058278333	0.987363058278333	1
